Ultralife Corp. has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $49.8 million from the US Government’s Defense Logistic Agency (DLA) for its hybrid lithium manganese dioxide/carbon monofluoride (CFx) non-rechargeable BA-5790 and BA-5795 batteries. The award is for five years with the amounts and timing of deliveries at the discretion of the DLA. Initial deliveries under this contract are expected to begin by the first quarter of 2019.
“Ultralife is a long-standing supplier to the US military focused on the continued development of new products to meet the ongoing needs of the warfighter. Building on the success of our existing lithium manganese dioxide family of primary batteries, our new CFx batteries deliver 1.5 times the energy in the same size and weight as our legacy batteries making them ideal for longer duration missions, while maintaining our proven safety, performance, and reliability under the toughest of conditions,” said Michael D. Popielec, president and CEO.